HOME >> BIOLOGY >> NEWS
In a tiny squid, bacterial toxin governs organ development

MADISON - In a tiny Pacific Ocean squid, a toxic molecule that causes whooping cough and gonorrhea in humans has been found to be a critical catalyst for organ development.

The toxin, produced by different types of bacteria in different hosts, is known as tracheal cytotoxin. And the astonishing discovery that it can be either good or bad - depending on its biological context - promises to rattle long-held perceptions of microbes and their role as pathogens.

The new work, funded by the National Institutes of Health, was reported this week (Nov. 12) in the journal Science.

That the same toxic molecule produced by different bacteria in different host animals plays such disparate roles - disease and massive tissue damage on the one hand, and critical organ development on the other - may force biologists to rethink the relationship between the world's many microorganisms and their host plants and animals, according to Margaret McFall-Ngai, a University of Wisconsin-Madison professor of medical microbiology and the corresponding author of the Science paper.

"It is all context dependent," says McFall-Ngai. "It has to be that we have mechanisms to use these molecules in different ways. Until now, molecules of a virulent nature have not been recognized as having essential roles in development."

In the diminutive Hawaiian bobtail squid, the toxin was found to spur the development of a structure, a light-producing organ that acts as a sort of "Klingon cloaking device," mimicking starlight to confuse hungry predators lurking in the depths. In humans, the same toxic molecule, produced by different species of bacteria, causes massive tissue damage in the lungs in the case of whooping cough, and in the fallopian tubes in the case of gonorrhea.

When the squid are born, they are about half the size of a grain of rice, and they must acquire the toxin-producing bacteria from their oc
'"/>

Contact: Margaret McFall-Ngai
mjmcfallngai@wisc.edu
608-262-2393
University of Wisconsin-Madison
11-Nov-2004


Page: 1 2 3

Related biology news :

1. A new plant-bacterial symbiotic mechanism promising
2. UCF professor finds bacterial pathogen may be key to understanding cancer development
3. Researchers discover acquired DNA key to certain bacterial infection
4. Hot on the TRAIL of controlling inflammation in bacterial meningitis
5. A new plant-bacterial symbiotic mechanism promising for crop applications
6. Researchers develop way to calculate speed of bacterial sex
7. Gallium: A new antibacterial agent?
8. New antibacterials being developed to tackle MRSA superbug
9. The pull of bacterial chromosome segregation
10. Green plants share bacterial toxin
11. ASU researchers test antibacterial effects of healing clays

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: tiny squid bacterial toxin governs organ development

(Date:6/15/2015)... , June 16, 2015 ... Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies ... Forecast to 2020" published by MarketsandMarkets, The Natural Language ... at a CAGR of 18.4% for the forecast period ... and   46 F igures spread   through ...
(Date:6/10/2015)... 2015 According to a ... Technology (Ultrasound, TOF, Structured Light, Stereo Vision), Type(Image, ... and by Geography - Trends & Forecast to ... is expected to reach $3,319.71 Million by 2020, ... and 2020. Browse 71 market data ...
(Date:6/5/2015)... 5, 2015  Intrexon Corporation ("Intrexon") (NYSE: XON ... it has determined the final distribution ratio relating to ... shares of ZIOPHARM Oncology, Inc. ("ZIOPHARM") (NASDAQ: ZIOP ... the distribution date, as a pro rata dividend on ... purchase shares of Intrexon common stock ("Warrants"), outstanding on ...
Breaking Biology News(10 mins):Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 53D Sensor Market Worth $3,319.71 Million by 2020 23D Sensor Market Worth $3,319.71 Million by 2020 33D Sensor Market Worth $3,319.71 Million by 2020 4Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 2Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 3Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 4
(Date:6/29/2015)... ... 2015 , ... The global microfluidics market is expected to ... to 2020). The market is mainly driven by the rising geriatric population, growing ... lack of adequate healthcare and research infrastructure in emerging markets, dearth of skilled ...
(Date:6/29/2015)... 2015  Neuralstem, Inc. (NYSE MKT: CUR), a biopharmaceutical ... molecule and cell therapy treatments for central nervous system ... listing on the NASDAQ Capital Market under the symbol ... on the NYSE MKT until the market close on ... is expected to commence on July 13, 2015. ...
(Date:6/29/2015)... , June 29, 2015   For the seventh year ... to assess their overall digital maturity called the ... these companies are not maturing fast enough. While it,s ... in numerous ways overall and customers are increasingly "digital ... of digital customer engagement.  ...
(Date:6/26/2015)... VANCOUVER , June 26, 2015 /PRNewswire/ - iCo ... ICOTF), today announced that all nominees listed in ... as directors at its 2015 Annual Meeting of ... a vote by ballot, the following 5 nominees ... iCo Therapeutics to serve until the Company,s next ...
Breaking Biology Technology:Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 2Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 3Results from Digital Maturity Study Show Pharma Lagging 2Results from Digital Maturity Study Show Pharma Lagging 3Results from Digital Maturity Study Show Pharma Lagging 4iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 2iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 3
Cached News: